CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+8.48%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.8B
AUM Growth
+$14.8B
(+4.4%)
Cap. Flow
-$279M
Cap. Flow
% of AUM
-1.89%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
926
New
50
Increased
256
Reduced
456
Closed
57
Top Buys
| 1 |
Mercado Libre
MELI
|
$41.1M |
| 2 |
Darling Ingredients
DAR
|
$37M |
| 3 |
Johnson & Johnson
JNJ
|
$34.5M |
| 4 |
Veru
VERU
|
$34M |
| 5 |
MetLife
MET
|
$31.5M |
Top Sells
| 1 |
PepsiCo
PEP
|
$46.7M |
| 2 |
Nike
NKE
|
$42.5M |
| 3 |
Illinois Tool Works
ITW
|
$37M |
| 4 |
Gilead Sciences
GILD
|
$32.3M |
| 5 |
Merck
MRK
|
$30.3M |
Sector Composition
| 1 | Healthcare | 33.31% |
| 2 | Technology | 22.85% |
| 3 | Financials | 10.04% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Industrials | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANSS
76
DELISTED
Ansys
ANSS
| $46.8M | 0.32% |
193,583
+20,629
| +12% | +$4.98M |
|
77
Cadence Design Systems
CDNS
$94.6B
| $46M | 0.31% |
286,173
+87,821
| +44% | +$14.1M |
|
78
MasTec
MTZ
$14.2B
| $45.7M | 0.31% |
535,704
+2,430
| +0.5% | +$207K |
|
79
Starbucks
SBUX
$99.2B
| $45.5M | 0.31% |
458,408
-182,515
| -28% | -$18.1M |
|
80
Intuitive Surgical
ISRG
$158B
| $45.2M | 0.3% |
170,170
-21,012
| -11% | -$5.58M |
|
81
Salesforce
CRM
$245B
| $43.9M | 0.3% |
330,982
-170,132
| -34% | -$22.6M |
|
82
Consolidated Edison
ED
$35.3B
| $43.8M | 0.3% |
459,287
+224,278
| +95% | +$21.4M |
|
83
Colgate-Palmolive
CL
$67.7B
| $43.7M | 0.29% |
554,380
+88,832
| +19% | +$7M |
|
84
Automatic Data Processing
ADP
$121B
| $43.2M | 0.29% |
180,800
-33,082
| -15% | -$7.9M |
|
85
PNC Financial Services
PNC
$80.7B
| $42.3M | 0.29% |
267,685
+19,770
| +8% | +$3.12M |
|
86
AstraZeneca
AZN
$255B
| $40.6M | 0.27% |
598,543
-11,484
| -2% | -$779K |
|
87
AbbVie
ABBV
$374B
| $40.4M | 0.27% |
250,176
-69,902
| -22% | -$11.3M |
|
88
Verizon
VZ
$184B
| $39.4M | 0.27% |
999,275
-80,604
| -7% | -$3.18M |
|
89
Arch Capital
ACGL
$34.7B
| $38.1M | 0.26% |
607,080
-184,394
| -23% | -$11.6M |
|
90
Allstate
ALL
$53.9B
| $37.9M | 0.26% |
279,523
+110,473
| +65% | +$15M |
|
91
Halozyme
HALO
$8.75B
| $37.1M | 0.25% |
652,302
-1,373
| -0.2% | -$78.1K |
|
92
NextEra Energy, Inc.
NEE
$148B
| $37M | 0.25% |
442,508
+76,436
| +21% | +$6.39M |
|
93
Mondelez International
MDLZ
$79.3B
| $36.8M | 0.25% |
551,906
+308,257
| +127% | +$20.5M |
|
94
Bio-Rad Laboratories Class A
BIO
$7.8B
| $36.4M | 0.25% |
86,478
-9,157
| -10% | -$3.85M |
|
95
Toronto Dominion Bank
TD
$128B
| $36.2M | 0.24% |
560,252
-62,533
| -10% | -$4.05M |
|
96
Exelixis
EXEL
$9.95B
| $36M | 0.24% |
2,243,038
+172,085
| +8% | +$2.76M |
|
97
Stryker
SYK
$149B
| $35.7M | 0.24% |
146,181
+91,477
| +167% | +$22.4M |
|
98
Estee Lauder
EL
$33.1B
| $35.3M | 0.24% |
142,368
-87,276
| -38% | -$21.7M |
|
99
Otis Worldwide
OTIS
$33.6B
| $34.8M | 0.23% |
444,718
-91,822
| -17% | -$7.19M |
|
|
BCYC
100
Bicycle Therapeutics
BCYC
$492M
| $34.8M | 0.23% |
1,175,211
-57,043
| -5% | -$1.69M |
|